nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps
|
Leader, A. |
|
2018 |
132 |
C |
p. 76-88 |
artikel |
2 |
A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives
|
Chiappa, Antonio |
|
2018 |
132 |
C |
p. 161-168 |
artikel |
3 |
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
|
D’Agostino, Mattia |
|
2018 |
132 |
C |
p. 9-16 |
artikel |
4 |
Crosstalk in cancer resistance and metastasis
|
Norouzi, Saeed |
|
2018 |
132 |
C |
p. 145-153 |
artikel |
5 |
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions
|
Riess, Hanno |
|
2018 |
132 |
C |
p. 169-179 |
artikel |
6 |
Editorial Board
|
|
|
2018 |
132 |
C |
p. IFC |
artikel |
7 |
Effect of long term aspirin use on the incidence of prostate cancer: A systematic review and meta-analysis
|
Sauer, C.M. |
|
2018 |
132 |
C |
p. 66-75 |
artikel |
8 |
Emerging paradigms in the treatment of liver metastases in colorectal cancer
|
Alhumaid, Abdulrahman |
|
2018 |
132 |
C |
p. 39-50 |
artikel |
9 |
Fertility preserving options for gynecologic malignancies: A review of current understanding and future directions
|
McKenzie, Nathalie D. |
|
2018 |
132 |
C |
p. 116-124 |
artikel |
10 |
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
|
Marchetti, C. |
|
2018 |
132 |
C |
p. 111-115 |
artikel |
11 |
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach
|
Belli, Carmen |
|
2018 |
132 |
C |
p. 125-129 |
artikel |
12 |
Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy
|
Taourel, P. |
|
2018 |
132 |
C |
p. 51-65 |
artikel |
13 |
One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?
|
Krajewska, Julia B. |
|
2018 |
132 |
C |
p. 1-8 |
artikel |
14 |
Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis
|
Montes de Jesus, F.M. |
|
2018 |
132 |
C |
p. 27-38 |
artikel |
15 |
Polymorphisms in non-coding RNAs and risk of colorectal cancer: A systematic review and meta-analysis
|
Alidoust, Maryam |
|
2018 |
132 |
C |
p. 100-110 |
artikel |
16 |
Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data
|
van Marcke, C. |
|
2018 |
132 |
C |
p. 138-144 |
artikel |
17 |
The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review
|
Dolan, Ross D. |
|
2018 |
132 |
C |
p. 130-137 |
artikel |
18 |
The role of Cancer/Testis Antigens in Multiple Myeloma pathogenesis and their application in disease monitoring and therapy
|
Shires, Karen |
|
2018 |
132 |
C |
p. 17-26 |
artikel |
19 |
The role of endothelial colony forming cells in kidney cancer’s pathogenesis, and in resistance to anti-VEGFR agents and mTOR inhibitors: A speculative review
|
Poletto, Valentina |
|
2018 |
132 |
C |
p. 89-99 |
artikel |
20 |
To resect or not to resect: The hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer
|
Gelsomino, Fabio |
|
2018 |
132 |
C |
p. 154-160 |
artikel |